ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Hyperthyroidism Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-10V14301
Home | Market Reports | Health| Health Conditions| Endocrine Conditions
Global Hyperthyroidism Treatment Market Research Report 2023
BUY CHAPTERS

Global Hyperthyroidism Treatment Market Research Report 2025

Code: QYRE-Auto-10V14301
Report
May 2025
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
Herbrand PharmaChemicals
Shanghai Zhaohui Pharmaceutical
Beijing Yanjing Pharmaceutical
Jinghua Pharmaceutical Group
Guangzhou Kanghe Pharmaceutical
Zigong Honghe Pharmaceutical
Guangdong Huanan Pharmaceutical
Zibo Wankang Pharmaceutical Chemical
Qilu Pharmaceutical

Hyperthyroidism Treatment Market Size

The global market for Hyperthyroidism Treatment was valued at US$ 516 million in the year 2024 and is projected to reach a revised size of US$ 784 million by 2031, growing at a CAGR of 6.2% during the forecast period.

Hyperthyroidism Treatment Market

Hyperthyroidism Treatment Market

Antithyroid medications are drugs that are used to treat hyperthyroidism, a condition in which the thyroid gland produces too much thyroid hormone. These medications work by blocking the production of thyroid hormone in the thyroid gland.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Hyperthyroidism Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hyperthyroidism Treatment.
The Hyperthyroidism Treatment market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Hyperthyroidism Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hyperthyroidism Treatment manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Hyperthyroidism Treatment Market Report

Report Metric Details
Report Name Hyperthyroidism Treatment Market
Accounted market size in year US$ 516 million
Forecasted market size in 2031 US$ 784 million
CAGR 6.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical, Zibo Wankang Pharmaceutical Chemical, Qilu Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Hyperthyroidism Treatment manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Hyperthyroidism Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Hyperthyroidism Treatment Market growing?

Ans: The Hyperthyroidism Treatment Market witnessing a CAGR of 6.2% during the forecast period 2025-2031.

What is the Hyperthyroidism Treatment Market size in 2031?

Ans: The Hyperthyroidism Treatment Market size in 2031 will be US$ 784 million.

Who are the main players in the Hyperthyroidism Treatment Market report?

Ans: The main players in the Hyperthyroidism Treatment Market are Merck, Herbrand PharmaChemicals, Shanghai Zhaohui Pharmaceutical, Beijing Yanjing Pharmaceutical, Jinghua Pharmaceutical Group, Guangzhou Kanghe Pharmaceutical, Zigong Honghe Pharmaceutical, Guangdong Huanan Pharmaceutical, Zibo Wankang Pharmaceutical Chemical, Qilu Pharmaceutical

What are the Application segmentation covered in the Hyperthyroidism Treatment Market report?

Ans: The Applications covered in the Hyperthyroidism Treatment Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Hyperthyroidism Treatment Market report?

Ans: The Types covered in the Hyperthyroidism Treatment Market report are Methimazole, Propylthiouracil, Other

Recommended Reports

Endocrine Disorders Treatment

Hyper-Related Treatments

Thyroid Disease Treatments

1 Hyperthyroidism Treatment Market Overview
1.1 Product Definition
1.2 Hyperthyroidism Treatment by Type
1.2.1 Global Hyperthyroidism Treatment Market Value Comparison by Type (2024 VS 2031)
1.2.2 Methimazole
1.2.3 Propylthiouracil
1.2.4 Other
1.3 Hyperthyroidism Treatment by Application
1.3.1 Global Hyperthyroidism Treatment Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Hyperthyroidism Treatment Market Size Estimates and Forecasts
1.4.1 Global Hyperthyroidism Treatment Revenue 2020-2031
1.4.2 Global Hyperthyroidism Treatment Sales 2020-2031
1.4.3 Global Hyperthyroidism Treatment Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Hyperthyroidism Treatment Market Competition by Manufacturers
2.1 Global Hyperthyroidism Treatment Sales Market Share by Manufacturers (2020-2025)
2.2 Global Hyperthyroidism Treatment Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Hyperthyroidism Treatment Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Hyperthyroidism Treatment, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Hyperthyroidism Treatment, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hyperthyroidism Treatment, Product Type & Application
2.7 Global Key Manufacturers of Hyperthyroidism Treatment, Date of Enter into This Industry
2.8 Global Hyperthyroidism Treatment Market Competitive Situation and Trends
2.8.1 Global Hyperthyroidism Treatment Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Hyperthyroidism Treatment Players Market Share by Revenue
2.8.3 Global Hyperthyroidism Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Hyperthyroidism Treatment Market Scenario by Region
3.1 Global Hyperthyroidism Treatment Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Hyperthyroidism Treatment Sales by Region: 2020-2031
3.2.1 Global Hyperthyroidism Treatment Sales by Region: 2020-2025
3.2.2 Global Hyperthyroidism Treatment Sales by Region: 2026-2031
3.3 Global Hyperthyroidism Treatment Revenue by Region: 2020-2031
3.3.1 Global Hyperthyroidism Treatment Revenue by Region: 2020-2025
3.3.2 Global Hyperthyroidism Treatment Revenue by Region: 2026-2031
3.4 North America Hyperthyroidism Treatment Market Facts & Figures by Country
3.4.1 North America Hyperthyroidism Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Hyperthyroidism Treatment Sales by Country (2020-2031)
3.4.3 North America Hyperthyroidism Treatment Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hyperthyroidism Treatment Market Facts & Figures by Country
3.5.1 Europe Hyperthyroidism Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Hyperthyroidism Treatment Sales by Country (2020-2031)
3.5.3 Europe Hyperthyroidism Treatment Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hyperthyroidism Treatment Market Facts & Figures by Region
3.6.1 Asia Pacific Hyperthyroidism Treatment Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Hyperthyroidism Treatment Sales by Region (2020-2031)
3.6.3 Asia Pacific Hyperthyroidism Treatment Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Hyperthyroidism Treatment Market Facts & Figures by Country
3.7.1 Latin America Hyperthyroidism Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Hyperthyroidism Treatment Sales by Country (2020-2031)
3.7.3 Latin America Hyperthyroidism Treatment Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hyperthyroidism Treatment Market Facts & Figures by Country
3.8.1 Middle East and Africa Hyperthyroidism Treatment Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Hyperthyroidism Treatment Sales by Country (2020-2031)
3.8.3 Middle East and Africa Hyperthyroidism Treatment Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hyperthyroidism Treatment Sales by Type (2020-2031)
4.1.1 Global Hyperthyroidism Treatment Sales by Type (2020-2025)
4.1.2 Global Hyperthyroidism Treatment Sales by Type (2026-2031)
4.1.3 Global Hyperthyroidism Treatment Sales Market Share by Type (2020-2031)
4.2 Global Hyperthyroidism Treatment Revenue by Type (2020-2031)
4.2.1 Global Hyperthyroidism Treatment Revenue by Type (2020-2025)
4.2.2 Global Hyperthyroidism Treatment Revenue by Type (2026-2031)
4.2.3 Global Hyperthyroidism Treatment Revenue Market Share by Type (2020-2031)
4.3 Global Hyperthyroidism Treatment Price by Type (2020-2031)
5 Segment by Application
5.1 Global Hyperthyroidism Treatment Sales by Application (2020-2031)
5.1.1 Global Hyperthyroidism Treatment Sales by Application (2020-2025)
5.1.2 Global Hyperthyroidism Treatment Sales by Application (2026-2031)
5.1.3 Global Hyperthyroidism Treatment Sales Market Share by Application (2020-2031)
5.2 Global Hyperthyroidism Treatment Revenue by Application (2020-2031)
5.2.1 Global Hyperthyroidism Treatment Revenue by Application (2020-2025)
5.2.2 Global Hyperthyroidism Treatment Revenue by Application (2026-2031)
5.2.3 Global Hyperthyroidism Treatment Revenue Market Share by Application (2020-2031)
5.3 Global Hyperthyroidism Treatment Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Hyperthyroidism Treatment Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Herbrand PharmaChemicals
6.2.1 Herbrand PharmaChemicals Company Information
6.2.2 Herbrand PharmaChemicals Description and Business Overview
6.2.3 Herbrand PharmaChemicals Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Herbrand PharmaChemicals Hyperthyroidism Treatment Product Portfolio
6.2.5 Herbrand PharmaChemicals Recent Developments/Updates
6.3 Shanghai Zhaohui Pharmaceutical
6.3.1 Shanghai Zhaohui Pharmaceutical Company Information
6.3.2 Shanghai Zhaohui Pharmaceutical Description and Business Overview
6.3.3 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Product Portfolio
6.3.5 Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
6.4 Beijing Yanjing Pharmaceutical
6.4.1 Beijing Yanjing Pharmaceutical Company Information
6.4.2 Beijing Yanjing Pharmaceutical Description and Business Overview
6.4.3 Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Product Portfolio
6.4.5 Beijing Yanjing Pharmaceutical Recent Developments/Updates
6.5 Jinghua Pharmaceutical Group
6.5.1 Jinghua Pharmaceutical Group Company Information
6.5.2 Jinghua Pharmaceutical Group Description and Business Overview
6.5.3 Jinghua Pharmaceutical Group Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Jinghua Pharmaceutical Group Hyperthyroidism Treatment Product Portfolio
6.5.5 Jinghua Pharmaceutical Group Recent Developments/Updates
6.6 Guangzhou Kanghe Pharmaceutical
6.6.1 Guangzhou Kanghe Pharmaceutical Company Information
6.6.2 Guangzhou Kanghe Pharmaceutical Description and Business Overview
6.6.3 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Product Portfolio
6.6.5 Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
6.7 Zigong Honghe Pharmaceutical
6.7.1 Zigong Honghe Pharmaceutical Company Information
6.7.2 Zigong Honghe Pharmaceutical Description and Business Overview
6.7.3 Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Product Portfolio
6.7.5 Zigong Honghe Pharmaceutical Recent Developments/Updates
6.8 Guangdong Huanan Pharmaceutical
6.8.1 Guangdong Huanan Pharmaceutical Company Information
6.8.2 Guangdong Huanan Pharmaceutical Description and Business Overview
6.8.3 Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Product Portfolio
6.8.5 Guangdong Huanan Pharmaceutical Recent Developments/Updates
6.9 Zibo Wankang Pharmaceutical Chemical
6.9.1 Zibo Wankang Pharmaceutical Chemical Company Information
6.9.2 Zibo Wankang Pharmaceutical Chemical Description and Business Overview
6.9.3 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Product Portfolio
6.9.5 Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
6.10 Qilu Pharmaceutical
6.10.1 Qilu Pharmaceutical Company Information
6.10.2 Qilu Pharmaceutical Description and Business Overview
6.10.3 Qilu Pharmaceutical Hyperthyroidism Treatment Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Qilu Pharmaceutical Hyperthyroidism Treatment Product Portfolio
6.10.5 Qilu Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hyperthyroidism Treatment Industry Chain Analysis
7.2 Hyperthyroidism Treatment Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hyperthyroidism Treatment Production Mode & Process Analysis
7.4 Hyperthyroidism Treatment Sales and Marketing
7.4.1 Hyperthyroidism Treatment Sales Channels
7.4.2 Hyperthyroidism Treatment Distributors
7.5 Hyperthyroidism Treatment Customer Analysis
8 Hyperthyroidism Treatment Market Dynamics
8.1 Hyperthyroidism Treatment Industry Trends
8.2 Hyperthyroidism Treatment Market Drivers
8.3 Hyperthyroidism Treatment Market Challenges
8.4 Hyperthyroidism Treatment Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
Herbrand PharmaChemicals
Shanghai Zhaohui Pharmaceutical
Beijing Yanjing Pharmaceutical
Jinghua Pharmaceutical Group
Guangzhou Kanghe Pharmaceutical
Zigong Honghe Pharmaceutical
Guangdong Huanan Pharmaceutical
Zibo Wankang Pharmaceutical Chemical
Qilu Pharmaceutical
List of Tables
 Table 1. Global Hyperthyroidism Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Hyperthyroidism Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Hyperthyroidism Treatment Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Hyperthyroidism Treatment Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Hyperthyroidism Treatment Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Hyperthyroidism Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Hyperthyroidism Treatment Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Hyperthyroidism Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Hyperthyroidism Treatment, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Hyperthyroidism Treatment, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Hyperthyroidism Treatment, Product Type & Application
 Table 12. Global Key Manufacturers of Hyperthyroidism Treatment, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Hyperthyroidism Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hyperthyroidism Treatment as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Hyperthyroidism Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Hyperthyroidism Treatment Sales by Region (2020-2025) & (K Units)
 Table 18. Global Hyperthyroidism Treatment Sales Market Share by Region (2020-2025)
 Table 19. Global Hyperthyroidism Treatment Sales by Region (2026-2031) & (K Units)
 Table 20. Global Hyperthyroidism Treatment Sales Market Share by Region (2026-2031)
 Table 21. Global Hyperthyroidism Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Hyperthyroidism Treatment Revenue Market Share by Region (2020-2025)
 Table 23. Global Hyperthyroidism Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Hyperthyroidism Treatment Revenue Market Share by Region (2026-2031)
 Table 25. North America Hyperthyroidism Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Hyperthyroidism Treatment Sales by Country (2020-2025) & (K Units)
 Table 27. North America Hyperthyroidism Treatment Sales by Country (2026-2031) & (K Units)
 Table 28. North America Hyperthyroidism Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Hyperthyroidism Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Hyperthyroidism Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Hyperthyroidism Treatment Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Hyperthyroidism Treatment Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Hyperthyroidism Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Hyperthyroidism Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Hyperthyroidism Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Hyperthyroidism Treatment Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Hyperthyroidism Treatment Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Hyperthyroidism Treatment Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Hyperthyroidism Treatment Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Hyperthyroidism Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Hyperthyroidism Treatment Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Hyperthyroidism Treatment Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Hyperthyroidism Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Hyperthyroidism Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Hyperthyroidism Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Hyperthyroidism Treatment Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Hyperthyroidism Treatment Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Hyperthyroidism Treatment Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Hyperthyroidism Treatment Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Hyperthyroidism Treatment Sales (K Units) by Type (2020-2025)
 Table 51. Global Hyperthyroidism Treatment Sales (K Units) by Type (2026-2031)
 Table 52. Global Hyperthyroidism Treatment Sales Market Share by Type (2020-2025)
 Table 53. Global Hyperthyroidism Treatment Sales Market Share by Type (2026-2031)
 Table 54. Global Hyperthyroidism Treatment Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Hyperthyroidism Treatment Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Hyperthyroidism Treatment Revenue Market Share by Type (2020-2025)
 Table 57. Global Hyperthyroidism Treatment Revenue Market Share by Type (2026-2031)
 Table 58. Global Hyperthyroidism Treatment Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Hyperthyroidism Treatment Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Hyperthyroidism Treatment Sales (K Units) by Application (2020-2025)
 Table 61. Global Hyperthyroidism Treatment Sales (K Units) by Application (2026-2031)
 Table 62. Global Hyperthyroidism Treatment Sales Market Share by Application (2020-2025)
 Table 63. Global Hyperthyroidism Treatment Sales Market Share by Application (2026-2031)
 Table 64. Global Hyperthyroidism Treatment Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Hyperthyroidism Treatment Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Hyperthyroidism Treatment Revenue Market Share by Application (2020-2025)
 Table 67. Global Hyperthyroidism Treatment Revenue Market Share by Application (2026-2031)
 Table 68. Global Hyperthyroidism Treatment Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Hyperthyroidism Treatment Price (US$/Unit) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Merck Hyperthyroidism Treatment Product
 Table 74. Merck Recent Developments/Updates
 Table 75. Herbrand PharmaChemicals Company Information
 Table 76. Herbrand PharmaChemicals Description and Business Overview
 Table 77. Herbrand PharmaChemicals Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Herbrand PharmaChemicals Hyperthyroidism Treatment Product
 Table 79. Herbrand PharmaChemicals Recent Developments/Updates
 Table 80. Shanghai Zhaohui Pharmaceutical Company Information
 Table 81. Shanghai Zhaohui Pharmaceutical Description and Business Overview
 Table 82. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Shanghai Zhaohui Pharmaceutical Hyperthyroidism Treatment Product
 Table 84. Shanghai Zhaohui Pharmaceutical Recent Developments/Updates
 Table 85. Beijing Yanjing Pharmaceutical Company Information
 Table 86. Beijing Yanjing Pharmaceutical Description and Business Overview
 Table 87. Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Beijing Yanjing Pharmaceutical Hyperthyroidism Treatment Product
 Table 89. Beijing Yanjing Pharmaceutical Recent Developments/Updates
 Table 90. Jinghua Pharmaceutical Group Company Information
 Table 91. Jinghua Pharmaceutical Group Description and Business Overview
 Table 92. Jinghua Pharmaceutical Group Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Jinghua Pharmaceutical Group Hyperthyroidism Treatment Product
 Table 94. Jinghua Pharmaceutical Group Recent Developments/Updates
 Table 95. Guangzhou Kanghe Pharmaceutical Company Information
 Table 96. Guangzhou Kanghe Pharmaceutical Description and Business Overview
 Table 97. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Guangzhou Kanghe Pharmaceutical Hyperthyroidism Treatment Product
 Table 99. Guangzhou Kanghe Pharmaceutical Recent Developments/Updates
 Table 100. Zigong Honghe Pharmaceutical Company Information
 Table 101. Zigong Honghe Pharmaceutical Description and Business Overview
 Table 102. Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Zigong Honghe Pharmaceutical Hyperthyroidism Treatment Product
 Table 104. Zigong Honghe Pharmaceutical Recent Developments/Updates
 Table 105. Guangdong Huanan Pharmaceutical Company Information
 Table 106. Guangdong Huanan Pharmaceutical Description and Business Overview
 Table 107. Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Guangdong Huanan Pharmaceutical Hyperthyroidism Treatment Product
 Table 109. Guangdong Huanan Pharmaceutical Recent Developments/Updates
 Table 110. Zibo Wankang Pharmaceutical Chemical Company Information
 Table 111. Zibo Wankang Pharmaceutical Chemical Description and Business Overview
 Table 112. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Zibo Wankang Pharmaceutical Chemical Hyperthyroidism Treatment Product
 Table 114. Zibo Wankang Pharmaceutical Chemical Recent Developments/Updates
 Table 115. Qilu Pharmaceutical Company Information
 Table 116. Qilu Pharmaceutical Description and Business Overview
 Table 117. Qilu Pharmaceutical Hyperthyroidism Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Qilu Pharmaceutical Hyperthyroidism Treatment Product
 Table 119. Qilu Pharmaceutical Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Hyperthyroidism Treatment Distributors List
 Table 123. Hyperthyroidism Treatment Customers List
 Table 124. Hyperthyroidism Treatment Market Trends
 Table 125. Hyperthyroidism Treatment Market Drivers
 Table 126. Hyperthyroidism Treatment Market Challenges
 Table 127. Hyperthyroidism Treatment Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Hyperthyroidism Treatment
 Figure 2. Global Hyperthyroidism Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Hyperthyroidism Treatment Market Share by Type: 2024 & 2031
 Figure 4. Methimazole Product Picture
 Figure 5. Propylthiouracil Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Hyperthyroidism Treatment Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Hyperthyroidism Treatment Market Share by Application: 2024 & 2031
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Hyperthyroidism Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Hyperthyroidism Treatment Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Hyperthyroidism Treatment Sales (2020-2031) & (K Units)
 Figure 15. Global Hyperthyroidism Treatment Average Price (US$/Unit) & (2020-2031)
 Figure 16. Hyperthyroidism Treatment Report Years Considered
 Figure 17. Hyperthyroidism Treatment Sales Share by Manufacturers in 2024
 Figure 18. Global Hyperthyroidism Treatment Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Hyperthyroidism Treatment Players: Market Share by Revenue in Hyperthyroidism Treatment in 2024
 Figure 20. Hyperthyroidism Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Hyperthyroidism Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Hyperthyroidism Treatment Sales Market Share by Country (2020-2031)
 Figure 23. North America Hyperthyroidism Treatment Revenue Market Share by Country (2020-2031)
 Figure 24. United States Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Hyperthyroidism Treatment Sales Market Share by Country (2020-2031)
 Figure 27. Europe Hyperthyroidism Treatment Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Hyperthyroidism Treatment Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Hyperthyroidism Treatment Revenue Market Share by Region (2020-2031)
 Figure 35. China Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Hyperthyroidism Treatment Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Hyperthyroidism Treatment Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Hyperthyroidism Treatment Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Hyperthyroidism Treatment Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Hyperthyroidism Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Hyperthyroidism Treatment by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Hyperthyroidism Treatment by Type (2020-2031)
 Figure 54. Global Hyperthyroidism Treatment Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Hyperthyroidism Treatment by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Hyperthyroidism Treatment by Application (2020-2031)
 Figure 57. Global Hyperthyroidism Treatment Price (US$/Unit) by Application (2020-2031)
 Figure 58. Hyperthyroidism Treatment Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Hyperthyroidism Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antithyroid Medications for Hyperthyroidism Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antithyroid Preparations Market Research Report 2024
Global Antithyroid Drug Market Research Report 2024
Hypothyroidism Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Underactive Thyroid Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Thyroid Gland Disorders Treatment Market Research Report 2025
Anti Thyroid Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Levothyroxine Sodium Market Research Report 2025
Global Thyroid Tablets Market Research Report 2024
Thyroid Hormone Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Thyroid Hormone Replacement Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Injection Levothyroxine Sodium Market Research Report 2025
Global Graves Disease Treatment Market Research Report 2025
Global Methimazole Tablets Market Research Report 2024
Global Propyl Thiouracil Market Insights Forecast to 2030
Global Hypothyroidism Drugs Market Insights Forecast to 2030
Global Thyroid Preparations Market Research Report 2024
Global Injectable Thyroid Drug Market Research Report 2024
Sodium Iodine 131I Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Disposable Insulin Pen Needle Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33W11115
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Liraglutide Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11A9578
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Diabetes Care Products Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I8272
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Thyroid Gland Disorder Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16N11302
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions